Gyrus extends offer period for Somnus:
This article was originally published in Clinica
Gyrus and its US subsidiary Gyrus Acquisition received just over 86% acceptances from shareholders in Somnus. Gyrus has extended its offer until Monday June 11. After that, the remaining shareholders will get the same $3.11 a share as those accepting and the UK radiofrequency surgery company will become Somnus' new owner.